Aprogen Biologics Inc.
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
003060 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩), 서울특별시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aprogen Biologics Inc. is a biopharmaceutical company specializing in the research, development, and manufacturing of advanced biologic medicines. Founded in 2000, the company leverages proprietary technologies in antibody and recombinant protein engineering to create a pipeline of both novel drugs and biosimilars. Its portfolio is focused on developing biosimilar products for various major biologics, including infliximab, trastuzumab, and rituximab, alongside a range of novel drug candidates. The company aims to provide innovative and accessible medicines for the professional medication market.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Aprogen Biologics Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Aprogen Biologics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Aprogen Biologics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
